Dr. Abeer A. Kaldas, MD

Dr. Kaldas practices at Cardiac Ambulatory Surgery Center of Corpus Christi, LLC in Corpus Christi, Texas.

Dr. Kaldas' NPI, 1881826089, was assigned on August 20, 2009. Dr. Kaldas graduated from University of Assiut Faculty of Medicine in 1997. Dr. Kaldas holds Texas license P5194.

Dr. Kaldas' primary practice is Cardiac Ambulatory Surgery Center of Corpus Christi, LLC, at 1521 S Staples St, Corpus Christi, TX 78404 in Nueces County. The practice phone is (361) 888-7779.

Dr. Kaldas' primary practice is Cardiac Ambulatory Surgery Center of Corpus Christi, LLC in Corpus Christi, Texas. Dr. Kaldas is also affiliated with CHRISTUS Spohn Hospital Corpus Christi - Shoreline. The medical group on file is Sound Physicians. Dmand AI also links Dr. Kaldas to 4 more hospitals, 5 dialysis centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaldas practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kaldas' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kaldas is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kaldas' licenses on file in 3 states: Texas, California and Tennessee.

Dmand AI lists acute kidney failure, bladder disease, chronic anemia, chronic diabetes, chronic hypertension, chronic kidney disease, fluid and electrolyte imbalances and intellectual and developmental disabilities among the conditions Dr. Kaldas treats.

CMS data shows 5,673 Medicare services from Dr. Kaldas across 14 procedure codes in 2024, for 640 Medicare patients. Medicare paid $647,461 for them.

CMS counts 640 Medicare patients who saw Dr. Kaldas in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaldas' median patient age at 68, with 48% women.

In 2024, Dr. Kaldas wrote 3,149 Medicare Part D claims for 572 patients. 76% of them were for generic drugs. CMS names the drug for 2,768 of them, across 50 drugs with 11 or more claims each, at $947,339 in total drug cost. In 2023, CMS named 2,055 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Kaldas for performance year 2024, reported individually. Dr. Kaldas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaldas as offering telehealth.

CMS Open Payments shows 168 general payments to Dr. Kaldas from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Calliditas Therapeutics US Inc. paid the most, $739.

Dr. Kaldas graduated from University of Assiut Faculty of Medicine in 1997.

Dr. Kaldas is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.